Cancer is characterized by cell growth uncontrolled in tissue and doesn’t recognize apoptosis. Cheral® is an herbal medicinal product that contains meniran (Phyllanthus niruri) and turmeric (Curcuma longa). Those herbals have been known to contain some active compounds which have the pharmacological function, such as anticancer. Therefore, this study aims to identify Cheral® potential in inducing apoptosis in T47D breast cancer cells line as well as to describe their mechanism to induce apoptosis by in vitro and bioinformatic analysis. For the in vitro study, AnnexinV/PI dye was used and then analyzed using flow cytometry for apoptosis assay. Bioinformatic analysis was conducted for exploring mechanism Cheral® to induce apoptosis. The result from apoptosis assay showed that the Cheral® could induce apoptosis in T47D cells. Further investigation by bioinformatics indicated that some active compounds in Cheral® helped to regulate several proteins that involve in the apoptosis process. It is concluded that the Cheral® could have the potential as an anticancer in T47D cells through their ability to induce apoptosis. Further research regarding proteins related to such apoptosis process may prove necessary.

1.
T.
Khazaei
,
A.
McGuigan
and
R.
Mahadevan
,
Front. Physiol.
16
(
3
),
135
(
2012
).
2.
A.L.B.
Baba
and
C.
Catoi
,
Comparative Oncology
(
The Publishing House of the Romanian Academy
,
Roma
,
2007
).
3.
B.
Alberts
,
A.
Johnson
,
J.
Lewis
,
M.
Raff
,
K.
Roberts
and
P.
Walter
, “Cell Junctions”, in
Molecular Biology of the Cell
, (
Garland Science
,
New York, United States
,
2002
).
4.
R.S.Y.
Wong
,
J. Exp. Clin. Cancer. Res.
30
(
1
),
87
(
2011
).
5.
R.F.A.
Júnior
,
L.A.L.
Soares
,
C.R.C.
Porto
,
R.G.F.
Aquino
,
H.G.
Guedes
,
P.R.
Petrovick
,
T.P.
Souza
,
A.A.
Araújo
and
G.C.B.
Guerra
,
World J. Gastroenterol.
18
(
31
),
4162
6168
(
2012
).
6.
T.L.
Wargasetia
,
S.
Permana
and
N.
Widodo
,
Exp. Ther. Med.
16
(
4
),
2985
2991
(
2018
).
7.
A.
Bhanot
,
R.
Sharma
and
M.N.
Noolvi
,
Int. J. Phytomedicine.
3
,
09
26
(
2011
).
8.
A.
Mediani
,
F.
Abas
,
A.
Khatib
,
C.P.
Tan
,
I. S.
Ismail
,
K.
Shaari
,
A.
Ismail
and
N.H.
Lajis
,
Ind. Crop Prod.
77
(
2015
),
602
613
(
2015
).
9.
B.
Kocaadam
and
N.
Şanlier
,
Crit. Rev. Food Sci. Nutr.
57
(
13
),
2889
2895
(
2017
).
10.
J.
Ravindran
,
S.
Prasad
and
B.B.
Aggarwal
,
AAPS J.
11
(
3
),
495
510
(
2009
).
11.
S.
Baig
,
I.
Seevasant
,
J.
Mohamad
,
A.
Mukheem
,
H.Z.
Huri
and
T.
Kamarul
,
Cell Death Dis.
7
(
1
),
e2058
(
2016
).
12.
M.
Kuhn
,
C.
Mering
,
M.
Campillos
,
L.J.
Jensen
and
P.
Bork
,
Nucleic Acids Res.
36
,
D684
D688
(
2008
).
13.
Q.
Chen
,
P.
Li
,
Y.
Xu
,
Y.
Li
and
B.
Tang
,
Oncol. Rep.
33
(
2
),
840
848
(
2015
).
14.
D.S.
Lee
,
M.K.
Lee
and
J.H.
Kim
,
Anticancer Res.
29
(
12
),
5039
5044
(
2009
).
15.
W.
Li
,
Y.
Zhou
,
J.
Yang
,
H.
Li
,
H.
Zhang
and
P.
Zheng
,
Oncol Rep.
37
(
6
),
3459
3466
(
2017
).
16.
T.
Choudhuri
,
S.
Pal
,
M.L.
Agwarwal
,
T.
Das
and
G.
Sa
,
FEBS Letters.
512
(
1–3
),
334
3
(
2002
).
17.
D.
Karunagaran
,
R.
Rashmi
, and
T.R.S.
Kumar
,
Curr. Cancer Drug Targets.
5
(
2
), (
2005
).
18.
J.
Yang
,
P.
Xiao
,
J.
Sun
and
L.
Guo
.
J Buon
,
23
(
1
),
218
223
(
2018
).
This content is only available via PDF.